Iron status in thalassemia major patients after long-term subcutaneous desferrioxamine.
Kontopoulou-Griva
I
I
1st Regional Transfusion Center, Hippokration Hospital, Athens, Greece.
Hatzidimitriou-Papazacharia
K
K
Spiliotopoulou
J
J
Tsagarakis
N
N
Digenopoulou
E
E
D000293:Adolescent; D000328:Adult; D002648:Child; D003676:Deferoxamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D007501:Iron / Q000378:metabolism*; D008297:Male; D013156:Splenectomy; D013789:Thalassemia / Q000188:drug therapy* / Q000378:metabolism; D013997:Time Factors
D007501:Iron; D003676:Deferoxamine